IMMUNE-MEDIATED NECROTISING MYOPATHY

This adverse event was reported 591 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED NECROTISING MYOPATHY:

# Drug Count
0 ATORVASTATIN CALCIUM 137
1 ATORVASTATIN CALCIUM, FILM COATED 137
2 SIMVASTATIN 93
3 METFORMIN 56
4 ROSUVASTATIN CALCIUM 40
5 EZETIMIBE 33
6 ROSUVASTATIN 32
7 PREDNISOLONE 31
8 PREDNISONE 28
9 METHOTREXATE SODIUM 25
See all common drugs associated with IMMUNE-MEDIATED NECROTISING MYOPATHY

IMMUNE-MEDIATED NECROTISING MYOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ATORVASTATIN CALCIUM 137 0.0042
1 EZETIMIBE 33 0.0035
2 SIMVASTATIN 93 0.0006
3 PEMBROLIZUMAB 9 0.0005
4 DESOXIMETASONE 1 0.0004
5 RABEPRAZOLE 4 0.0004
6 AZATHIOPRINE 17 0.0004
7 PITAVASTATIN CALCIUM 2 0.0004
8 REPAGLINIDE 2 0.0003
9 ROSUVASTATIN CALCIUM 40 0.0003
See all drugs enriched for association with IMMUNE-MEDIATED NECROTISING MYOPATHY

These drug classes are most commonly taken by patients reporting IMMUNE-MEDIATED NECROTISING MYOPATHY:

# Drug class Count
0 Angiotensin Converting Enzyme Inhibitor [EPC] 12
See all common drug classes associated with IMMUNE-MEDIATED NECROTISING MYOPATHY

IMMUNE-MEDIATED NECROTISING MYOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Angiotensin Converting Enzyme Inhibitor [EPC] 12 0.0001
See all drug classes enriched for association with IMMUNE-MEDIATED NECROTISING MYOPATHY